A recent international clinical trial by C. Michael Gibson and colleagues investigated the efficacy of CSL112 (human Apolipoprotein A1) which helps in reducing the risk of recurrent cardiovascular events in patients who have experienced acute myocardial infarction. The findings were published in The New England Journal of Medicine and highlight the potential of CSL112 to […]
Recent research has suggested a potential link between hearing loss and an increased risk of dementia. However, the underlying mechanisms and how they relate to neurodegeneration and cognitive decline remain unclear. A new study sheds light on these relationships and their impact on dementia risk. The study was published in the Journal Of Neurology Neurosurgery […]
In a recent review, researchers have shed light on the safety profile of low-dose colchicine, offering reassuring evidence for its use in secondary prevention among patients with coronary artery disease. The study, drawing from a comprehensive analysis of contemporary systemic reviews, case reports, drug registries, and placebo-controlled trials, aims to inform healthcare professionals and patients […]
New research being presented at this year’s ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) has found compelling evidence that tuberculosis (TB) can have a lasting impact on the lungs of individuals who have been successfully treated for the disease. TB survivors have smaller lungs with narrower airways and slower air flow, the […]
Dysphotopsia, characterized by the perception of visual disturbances such as glare or halos, is a common concern following cataract surgery with intraocular lens (IOL) implantation. While transient dysphotopsia often resolves spontaneously, persistent dysphotopsia can significantly impact patient satisfaction and quality of life. Researchers have found in a new study that history of migraine was associated […]
Initial results from a recent Phase 1 clinical trial indicate that the experimental vaccine CTH522 could be a crucial tool against both ocular trachoma and urogenital chlamydia. The key findings were published in The Lancet Infectious Diseases. The CHLM-02 trial was conducted at the National Institute for Health Research Imperial Clinical Research Facility in London, […]
Guwahati: A third-year PG medico at the Department of Obstetrics and Gynaecology of Gauhati Medical College Hospital (GMCH) has been expelled by the college administration for a year after allegations were levelled against him of hitting a pregnant woman in the hospital. The incident reportedly took place in the labour room of the hospital. Sources informed TOI […]
New Delhi: The drug major Dr Reddy’s Labs has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to manufacture and market the anti-cancer drug Lenalidomide capsules 20mg (additional strength) with Phase-III clinical trial (CT) waiver. This came after Dr.Reddy’s Labs presented the proposal for manufacturing […]
Mumbai: Mac-Chem Products (India) Pvt. Ltd. (Mac-Chem) announced today the successful renewal of its European Union Goods Manufacturing Practices) (EU-GMP certification for its manufacturing facility in Boisar. The approval marks a significant milestone for Mac-Chem in its journey of global leadership. The audit was conducted in October 2023 by Swissmedic Swiss Agency for Therapeutic Products. Speaking […]